OncoStem

OncoStem Diagnostics is a Bengaluru-based precision oncology company that develops AI-powered prognostic cancer tests to assess tumor aggressiveness and guide personalized treatment decisions. Founded in 2011 by Dr. Manjiri Bakre, OncoStem applies in-depth knowledge of tumor biology and machine learning to identify the unique characteristics of cancer recurrence risk in individual patients. The company's flagship product, CanAssist Breast, is a prognostic test for early-stage breast cancer (Stages 1 and 2) that helps oncologists determine whether a patient needs chemotherapy by predicting the likelihood of cancer recurrence. The test enables patients to potentially avoid the side effects of chemotherapy when their risk of recurrence is low. OncoStem is backed by Peak XV Partners (formerly Sequoia India) and is part of the broader movement to apply AI and genomics to precision diagnostics for cancer patients across India and globally.